182 related articles for article (PubMed ID: 23622119)
1. Unresolved issues in hematopoietic stem cell transplantation for severe combined immunodeficiency: need for safer conditioning and reduced late effects.
Horn B; Cowan MJ
J Allergy Clin Immunol; 2013 May; 131(5):1306-11. PubMed ID: 23622119
[TBL] [Abstract][Full Text] [Related]
2. Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.
Heimall J; Puck J; Buckley R; Fleisher TA; Gennery AR; Neven B; Slatter M; Haddad E; Notarangelo LD; Baker KS; Dietz AC; Duncan C; Pulsipher MA; Cowan MJ
Biol Blood Marrow Transplant; 2017 Mar; 23(3):379-387. PubMed ID: 28068510
[TBL] [Abstract][Full Text] [Related]
3. Long term outcomes of severe combined immunodeficiency: therapy implications.
Heimall J; Cowan MJ
Expert Rev Clin Immunol; 2017 Nov; 13(11):1029-1040. PubMed ID: 28918671
[TBL] [Abstract][Full Text] [Related]
4. HLA-haploidentical donor transplantation in severe combined immunodeficiency.
Friedrich W; Hönig M
Immunol Allergy Clin North Am; 2010 Feb; 30(1):31-44. PubMed ID: 20113885
[TBL] [Abstract][Full Text] [Related]
5. Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a PIDTC natural history study.
Heimall J; Logan BR; Cowan MJ; Notarangelo LD; Griffith LM; Puck JM; Kohn DB; Pulsipher MA; Parikh S; Martinez C; Kapoor N; O'Reilly R; Boyer M; Pai SY; Goldman F; Burroughs L; Chandra S; Kletzel M; Thakar M; Connelly J; Cuvelier G; Davila Saldana BJ; Shereck E; Knutsen A; Sullivan KE; DeSantes K; Gillio A; Haddad E; Petrovic A; Quigg T; Smith AR; Stenger E; Yin Z; Shearer WT; Fleisher T; Buckley RH; Dvorak CC
Blood; 2017 Dec; 130(25):2718-2727. PubMed ID: 29021228
[TBL] [Abstract][Full Text] [Related]
6. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
7. Host natural killer immunity is a key indicator of permissiveness for donor cell engraftment in patients with severe combined immunodeficiency.
Hassan A; Lee P; Maggina P; Xu JH; Moreira D; Slatter M; Nademi Z; Worth A; Adams S; Jones A; Cale C; Allwood Z; Rao K; Chiesa R; Amrolia P; Gaspar H; Davies EG; Veys P; Gennery A; Qasim W
J Allergy Clin Immunol; 2014 Jun; 133(6):1660-6. PubMed ID: 24794685
[TBL] [Abstract][Full Text] [Related]
8. Immune reconstitution after HSCT in SCID-a cohort of conditioned and unconditioned patients.
Manor U; Lev A; Simon AJ; Hutt D; Toren A; Bielorai B; Goldberg L; Stauber T; Somech R
Immunol Res; 2019 Jun; 67(2-3):166-175. PubMed ID: 31222511
[TBL] [Abstract][Full Text] [Related]
9. SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery.
Haddad E; Logan BR; Griffith LM; Buckley RH; Parrott RE; Prockop SE; Small TN; Chaisson J; Dvorak CC; Murnane M; Kapoor N; Abdel-Azim H; Hanson IC; Martinez C; Bleesing JJH; Chandra S; Smith AR; Cavanaugh ME; Jyonouchi S; Sullivan KE; Burroughs L; Skoda-Smith S; Haight AE; Tumlin AG; Quigg TC; Taylor C; Dávila Saldaña BJ; Keller MD; Seroogy CM; Desantes KB; Petrovic A; Leiding JW; Shyr DC; Decaluwe H; Teira P; Gillio AP; Knutsen AP; Moore TB; Kletzel M; Craddock JA; Aquino V; Davis JH; Yu LC; Cuvelier GDE; Bednarski JJ; Goldman FD; Kang EM; Shereck E; Porteus MH; Connelly JA; Fleisher TA; Malech HL; Shearer WT; Szabolcs P; Thakar MS; Vander Lugt MT; Heimall J; Yin Z; Pulsipher MA; Pai SY; Kohn DB; Puck JM; Cowan MJ; O'Reilly RJ; Notarangelo LD
Blood; 2018 Oct; 132(17):1737-1749. PubMed ID: 30154114
[TBL] [Abstract][Full Text] [Related]
10. Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium.
Thakar MS; Logan BR; Puck JM; Dunn EA; Buckley RH; Cowan MJ; O'Reilly RJ; Kapoor N; Satter LF; Pai SY; Heimall J; Chandra S; Ebens CL; Chellapandian D; Williams O; Burroughs LM; Saldana BD; Rayes A; Madden LM; Chandrakasan S; Bednarski JJ; DeSantes KB; Cuvelier GDE; Teira P; Gillio AP; Eissa H; Knutsen AP; Goldman FD; Aquino VM; Shereck EB; Moore TB; Caywood EH; Lugt MTV; Rozmus J; Broglie L; Yu LC; Shah AJ; Andolina JR; Liu X; Parrott RE; Dara J; Prockop S; Martinez CA; Kapadia M; Jyonouchi SC; Sullivan KE; Bleesing JJ; Chaudhury S; Petrovic A; Keller MD; Quigg TC; Parikh S; Shenoy S; Seroogy C; Rubin T; Decaluwe H; Routes JM; Torgerson TR; Leiding JW; Pulsipher MA; Kohn DB; Griffith LM; Haddad E; Dvorak CC; Notarangelo LD
Lancet; 2023 Jul; 402(10396):129-140. PubMed ID: 37352885
[TBL] [Abstract][Full Text] [Related]
11. Radiation-sensitive severe combined immunodeficiency: The arguments for and against conditioning before hematopoietic cell transplantation--what to do?
Cowan MJ; Gennery AR
J Allergy Clin Immunol; 2015 Nov; 136(5):1178-85. PubMed ID: 26055221
[TBL] [Abstract][Full Text] [Related]
12. SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID.
Schuetz C; Neven B; Dvorak CC; Leroy S; Ege MJ; Pannicke U; Schwarz K; Schulz AS; Hoenig M; Sparber-Sauer M; Gatz SA; Denzer C; Blanche S; Moshous D; Picard C; Horn BN; de Villartay JP; Cavazzana M; Debatin KM; Friedrich W; Fischer A; Cowan MJ
Blood; 2014 Jan; 123(2):281-9. PubMed ID: 24144642
[TBL] [Abstract][Full Text] [Related]
13. Radiosensitive severe combined immunodeficiency disease.
Dvorak CC; Cowan MJ
Immunol Allergy Clin North Am; 2010 Feb; 30(1):125-42. PubMed ID: 20113890
[TBL] [Abstract][Full Text] [Related]
14. Hematopoietic cell transplantation for sickle cell disease: updates and future directions.
Krishnamurti L
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):181-189. PubMed ID: 34889368
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival and late deaths after hematopoietic cell transplantation for primary immunodeficiency diseases and inborn errors of metabolism.
Eapen M; Ahn KW; Orchard PJ; Cowan MJ; Davies SM; Fasth A; Hassebroek A; Ayas M; Bonfim C; O'Brien TA; Gross TG; Horwitz M; Horwitz E; Kapoor N; Kurtzberg J; Majhail N; Ringden O; Szabolcs P; Veys P; Baker KS
Biol Blood Marrow Transplant; 2012 Sep; 18(9):1438-45. PubMed ID: 22430083
[TBL] [Abstract][Full Text] [Related]
16. Hematopoietic stem cell transplantation for severe combined immunodeficiency diseases.
Cowan MJ; Neven B; Cavazanna-Calvo M; Fischer A; Puck J
Biol Blood Marrow Transplant; 2008 Jan; 14(1 Suppl 1):73-5. PubMed ID: 18162224
[TBL] [Abstract][Full Text] [Related]
17. Transplantation outcomes for severe combined immunodeficiency, 2000-2009.
Pai SY; Logan BR; Griffith LM; Buckley RH; Parrott RE; Dvorak CC; Kapoor N; Hanson IC; Filipovich AH; Jyonouchi S; Sullivan KE; Small TN; Burroughs L; Skoda-Smith S; Haight AE; Grizzle A; Pulsipher MA; Chan KW; Fuleihan RL; Haddad E; Loechelt B; Aquino VM; Gillio A; Davis J; Knutsen A; Smith AR; Moore TB; Schroeder ML; Goldman FD; Connelly JA; Porteus MH; Xiang Q; Shearer WT; Fleisher TA; Kohn DB; Puck JM; Notarangelo LD; Cowan MJ; O'Reilly RJ
N Engl J Med; 2014 Jul; 371(5):434-46. PubMed ID: 25075835
[TBL] [Abstract][Full Text] [Related]
18. B-cell differentiation and IL-21 response in
Miggelbrink AM; Logan BR; Buckley RH; Parrott RE; Dvorak CC; Kapoor N; Abdel-Azim H; Prockop SE; Shyr D; Decaluwe H; Hanson IC; Gillio A; Dávila Saldaña BJ; Eibel H; Hopkins G; Walter JE; Whangbo JS; Kohn DB; Puck JM; Cowan MJ; Griffith LM; Haddad E; O'Reilly RJ; Notarangelo LD; Pai SY
Blood; 2018 Jun; 131(26):2967-2977. PubMed ID: 29728406
[TBL] [Abstract][Full Text] [Related]
19. Minimal dose of hematopoietic stem cell transplantation without myelosuppressive conditioning for T-B+NK- severe combined immunodeficiency.
Yi ES; Ju HY; Cho HW; Lee JW; Sung KW; Koo HH; Kang ES; Ahn KM; Kim YJ; Yoo KH
Clin Immunol; 2023 Mar; 248():109269. PubMed ID: 36804471
[TBL] [Abstract][Full Text] [Related]
20. Hematopoietic Cell Transplantation for Inborn Errors of Immunity Other than Severe Combined Immunodeficiency in Japan: Retrospective Analysis for 1985-2016.
Miyamoto S; Umeda K; Kurata M; Yanagimachi M; Iguchi A; Sasahara Y; Okada K; Koike T; Tanoshima R; Ishimura M; Yamada M; Sato M; Takahashi Y; Kajiwara M; Kawaguchi H; Inoue M; Hashii Y; Yabe H; Kato K; Atsuta Y; Imai K; Morio T
J Clin Immunol; 2022 Apr; 42(3):529-545. PubMed ID: 34981329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
